SF 4601 would require manufacturers of menstrual products sold, offered for sale, or distributed in Minnesota to disclose on the outer product packaging any intentionally added synthetic ingredients contained in the product. The bill defines “outer product packaging” as the first packaging a consumer sees when a package contains multiple individual products. The disclosure requirement applies only to menstrual products with intentionally added synthetic ingredients, and it is framed as a labeling obligation rather than a product ban or ingredient restriction.
The bill is drafted as a new section in Minnesota Statutes chapter 325E, which governs commerce and consumer protections. It would create a specific packaging disclosure rule for menstrual products and direct enforcement through an existing enforcement provision in section 325E.3892, subdivision 3. In practical terms, the measure would affect manufacturers, distributors, and retailers of menstrual products in Minnesota by requiring updated packaging and compliance with state labeling standards.
Impact
SF 4601 would add a new consumer-labeling requirement to Minnesota’s commerce statutes, specifically chapter 325E, by creating section 325E.3893. It would require menstrual product manufacturers to identify intentionally added synthetic ingredients on outer packaging, thereby expanding state disclosure obligations for consumer goods. The bill would primarily affect manufacturers and sellers of menstrual products, who would need to review formulations, update packaging, and ensure compliance with Minnesota’s enforcement framework for commerce-related labeling violations.
Sentiment
The available record shows the bill was introduced and referred to the Senate Commerce and Consumer Protection Committee, but there are no committee transcripts or recorded votes provided. Based on the bill’s subject matter and structure, it appears to be a consumer transparency measure rather than a controversial regulatory restriction. The absence of recorded opposition or amendments in the provided materials suggests the bill had not yet generated a documented public debate in the available record.
Contention
No specific points of contention are documented in the provided materials because there are no committee hearing transcripts or votes. Potential areas of debate, if the bill were discussed, would likely include whether the disclosure requirement is sufficiently clear, the compliance burden on manufacturers, and whether synthetic ingredient labeling should be limited to menstrual products or extended to other consumer goods. However, these are inferred policy issues rather than recorded objections from the bill history provided.